Continuing Medical 


We're going Virtual!
An Update on the Treatment of Pain:
Chronic Non-Cancer Pain, Addiction and Mental Health*
Friday October 16, 2020 (full day)
More information to come.

This CME will occur one day prior to the PSA Annual Conference and requires a separate registration.

* Onsite registrations will not be available. Please register online prior to October 9, 2020. A pre course learning assessment and further information will be sent closer to the course date to identify your learning objectives. 

Course Overview

Main Presenter:

Please see all additional facilitators bios below

An Update on the Treatment of Pain: Chronic Non-Cancer Pain, Addiction and Mental Health will provide participant’s tools for assessment and management of chronic pain. It begins with an overview of the anatomy and physiology of pain and transitions to the epidemiology of chronic pain in Canada and its treatment.

Pharmacologic and non-pharmacologic options as described in recent guidelines will be discussed with an emphasis on the biopsychosocial treatment of chronic pain and the advantages of voluntary opioid deprescribing.

The evidence for medical cannabis will be reviewed. Addiction potential and risk mitigation strategies for opioids and cannabinoids will be presented. Participants will learn to identify and treat opioid use disorder (addiction) in the chronic pain population. Psychiatric comorbidities and their effect on chronic pain and their management will be addressed.

This comprehensive program on pain, addiction and mental health will provide a full day of education. 

Course Objectives

1. Describe the biology and epidemiology of pain.
2. Identify the cognitive pathogenesis of chronic pain.
3. Utilize and understand the 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain.
4. Review the evidence for medical cannabis in the treatment of chronic pain.
5. Formulate an evidence-based treatment plan for chronic pain in a bio-psycho-social format.
6. Utilize evidence-based screening tools for Chronic Pain, Addictions, and Mental Health
7. Conduct motivational interviewing skills to engage a patient in an active pain management program.
8. Identify neuropsychological strategies for patients to help reduce distress and pain.
9. Mitigate an approach to an inherited patient on opioids.
10. Create a discussion to introduce the idea of opioid tapering with a patient.
11. Recognize Opioid Use Disorder in pain patients and initiate treatment
12. Understand the treatment of Chronic Pain for those with Opioid Use Disorder
13. Recognize and treat psychiatric co-morbidities in chronic non-cancer pain

Course Program and Outcomes

Prior to the course participants are required to complete one hour of pre-course work including a pre-course needs assessment. Using common chronic pain case presentations, participants will become familiar with:

1. Conducting an appropriate pain assessment to evaluate of pain, mood, sleep and function during a clinical interview.
2. Applying the understanding of biology and cognitive processes in chronic pain when formulating patient management strategies.
3. Identify 90mg of Morphine Equivalent Daily Dose (MEDD) as a watchful dose in prescribing opioids for chronic, non-cancer pain.
4. Identifying and treating opioid use disorder in the pain population.
5. Outline and identify the different between CBD and THC from the perspective of risks, sedation, euphoric potential and analgesia.
6. Acknowledge therapeutic treatment strategies to break the fear avoidance cycle.
7. Demonstrate the safe and appropriate use of a naloxone kit.
8. Identify psychiatric comorbidities and their effect on chronic pain.
9. Engage physicians to discuss fear-avoidance in chronic pain patients.
10. Formulate and incorporate an opioid taper plan for their patient.
Onsite registrations will not be available. Please register online prior to October 9, 2020. A pre course learning assessment will be send closer tot he course date to identify your learning objectives. Please review the full information sheet here.

Claiming Your CME Credits

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the University of Calgary Office of Continuing Medical Education and Professional Development. You may claim a maximum of 7.5 hours (credits are automatically calculated).
Visit MAINPORT to record your learning and outcomes.
This program was co-developed with Alberta Health Services, Opioid Dependency Program and was planned to achieve scientific integrity, objectivity and balance.
Mainpro+ participants may earn additional certified credits by completing a Linking Learning exercise.


Screen Shot 2020-03-03 at 4.33.52 PM.png



President, Pain Society of Alberta
Alberta Pain Strategy - Opioid Working Group Chair

Dr. Rob Tanguay an FRCPC psychiatrist who is fellowship-trained and sub-specialized in both Addiction Medicine, certified under the International Society of Addiction’s Medicine (ISAM) and Canadian Society of Addiction’s Medicine (CSAM), and Pain Medicine. He is the Provincial Medical Lead for Opioid Dependency Treatment Training for Addictions and Mental Health, Alberta Health Services, the Executive Director of the Canadian Opioid Deprescribing Institute (CODi), the Executive Director of the Transitional Outpatient Patient Program for Pain (TOPPS), the President of the Pain Society of Alberta, the CSAM Regional Director for Alberta and NWT, and the Co-Chair of the Opioid Use in Pain Medicine working group for the Alberta Pain Strategy. Dr. Tanguay’s current clinical positions include Medical Lead of the TOPPS clinic (Transitional Outpatient Pain Program for Spine), Medical Lead of the Canadian Deprescribing Institute, and a Pain, Psychiatric, and Addictions Consultant for the Opioid Deprescribing Program, Alberta Health Services. He has been invited to be a keynote, plenary, and panel speaker at national and international conferences as well as for local events and is a Clinical Lecturer at the Cumming School of Medicine, University of Calgary.

Dr.  Rob Tanguay


Screen Shot 2020-03-03 at 4.34.02 PM.png


Dr. Ghosh completed his medical school at the University of Calgary and Internal Medicine training at the University of Alberta.  He splits his time between Edmonton at The University of Alberta Hospital and Calgary where he works with Calgary’s most vulnerable populations at The Alex and The Opioid Dependency Program.   He has a particular passion for working with individuals who live with homelessness, a history of corrections, immigrants, and First Nations populations.  He also has a passion for addiction research and education and enjoys travelling in his free time.  Dr. Ghosh has been a CSAM board representative as IT Liaison since 2018.

Dr. Monty Ghosh


Screen Shot 2020-03-03 at 4.34.11 PM.png

Keith King is a Registered Nurse with a Masters in Public Health and extensive experience in Mental Health, Addictions, & Public Health Nursing. With a firm grounding in harm-reduction, health promotion, and counselling, Keith brings a strength-based, inclusive and recovery-oriented frame to his work. He is currently undertaking his Ph.D. in Nursing at the University of Alberta while Lecturing and serving on a variety of boards and organizations in his community, and trying to keep fit and have fun while doing it all.  

Keith King


Screen Shot 2020-03-03 at 4.34.17 PM.png

Taylor has been a massage therapy educator in Vancouver BC for more than 10 years. He has worked with both the colleges and with the professional associations to improve the education Canadian massage therapists receive. Taylor has a full-time practise working primarily with people living with chronic pain, and is a continuing education provider for his colleagues, providing evidence-based continuing education courses focused around integrating research, and a biopsychosocial model into practice.

Taylor James Laviolette


Screen Shot 2020-03-03 at 4.34.26 PM.png

Dr. John Xavier Pereira is the President of the Pain Society of Alberta. He is a past Ronald Melzack Fellow of the McGill Pain Center and past Pfizer Canada Scholar in Persistent and Neuropathic Pain. He previously taught medical school and received teaching awards from the classes of 2012, 2013 and 2014 at the University of Calgary. He has spoken on the topic of chronic pain both nationally and internationally, most recently in Auckland, New Zealand and the at Centre for Disease Control (CDC) in Atlanta. He represented Western Canada on the committee of physicians who wrote the country's national guidelines for the diagnosis and treatment of fibromyalgia. His dream of creating the world's foremost fibromyalgia treatment program has moved one step closer as FibroFOCUS won a 2016 Health Quality Council of Alberta Patient Experience Award.

Dr. John Pereira